University of Eastern Finland at ESGCT 2026

Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website

University of Eastern Finland brings 11 presentations to ESGCT 2026 in Hamburg. Its work covers lentiviral and AAV gene therapy for heart conditions, including prime editing of a cardiomyopathy mutation. Other strands cover large-scale vector and lipid nanoparticle production and new targets and models for glioblastoma.

OrganizationESGCT 2026 Attendance
Universities & institutes
Finnish university whose Kuopio institute researches viral vector gene therapy for cardiovascular disease.
Poster
Wed Oct 28
1:30pm–3:30pm
ADAMTS18 as a tumour microenvironment regulator for glioblastoma therapy
Oncolytic therapy & cancer gene therapy
Poster
Wed Oct 28
1:30pm–3:30pm
Comparability of lipid nanoparticles produced using herringbone and impingement jets mixing technologies
Manufacturing
Poster
Wed Oct 28
1:30pm–3:30pm
Pursuing ways to tackle glioblastoma – novel models, targets, therapies and biomarkers
Immunotherapy and CAR T cells
Poster
Wed Oct 28
1:30pm–3:30pm
Studying the effect of lentiviral vectors carrying Serca2a transgene in the Angiotensin II-induced hypertensive heart disease mouse model
Cardiovascular & Muscular diseases
Poster
Wed Oct 28
1:30pm–3:30pm
Towards safe and effective gene therapy of cardiac conditions with optimized lentiviral vectors
Lentiviral vectors / Integrative vectors
Poster
Thu Oct 29
2:00pm–4:00pm
Development of Prime editing targeting R14del Phospholamban
Gene Editing
Poster
Thu Oct 29
2:00pm–4:00pm
Improving the Efficacy of AAV-mediated Cardiac Gene Therapy by the Co-delivery of Programmed Death 1 Ligands
Immune responses to GT
Poster
Thu Oct 29
2:00pm–4:00pm
Large-scale production of lentiviral vectors for preclinical and clinical studies
Manufacturing
Poster
Thu Oct 29
2:00pm–4:00pm
Rational engineering of alphavirus-derived Trans-Amplifying RNAs for Transient Gene Therapy
Non viral delivery
Poster
Thu Oct 29
2:00pm–4:00pm
Regulated transgene expression in vitro and in vivo via riboswitches
AAVs / non integrative vectors
Poster
Thu Oct 29
2:00pm–4:00pm
Upscaling AAV6 production from flasks to a fixed-bed bioreactor for large scale pre-clinical and clinical studies
Manufacturing
Chair
Fri Oct 30
9:00am–10:30am
SESSION 11a: Cardio & muscular gene therapy
with Technical University of Munich
Rare and inherited disease

Explore the full ESGCT 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Hamburg. Leave your work email and we’ll be in touch.

Privacy

Download the full ESGCT 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from University of Eastern Finland

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction